EP Patent

EP0245913B1 — Process for preparing 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid

Assigned to Riker Laboratories Inc · Expires 1992-03-25 · 34y expired

What this patent protects

Patent listed against Zelboraf.

Drugs covered by this patent

Patent Metadata

Patent number
EP0245913B1
Jurisdiction
EP
Classification
—
Expires
1992-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Riker Laboratories Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.